MAYNE PHARMA GROUP LIMITED — Director's Dealing 2016

Sep 22, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity		Mayne Pharma Group Limited
ABN	76	115 832 963

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	William Phillip Hodges
Date of last notice	13 September 2016

Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	William P Hodges
Date of change	21 Sep 2016
No. of securities held prior tochange	8,069,554 Ordinary Fully Paid Shares
Class	Ordinary fully paid shares
Number acquired	Nil
Number disposed	1,330,000 Ordinary Fully Paid Shares
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	$2,660,270.06
No.ofsecuritiesheldafterchange	6,739,554 Ordinary Fully Paid Shares

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back	On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities orcontracts detailed above traded during a+closedperiodwherepriorwrittenclearance was required?	N/A
If so, was prior written clearance providedto allow the trade to proceed during thisperiod?	N/A
If prior written clearance was provided, onwhat date was thisprovided?	N/A

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011